Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin

Publisher： Karger

E-ISSN： 1423-0151|26|2|182-184

ISSN： 1011-7571

Source： Medical Principles and Practice, Vol.26, Iss.2, 2016-12, pp. : 182-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fidaxomicin inhibits toxin production in Clostridium difficile

By Babakhani Farah   Bouillaut Laurent   Sears Pamela   Sims Carlee   Gomez Abraham   Sonenshein Abraham L.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 3, 2013-03 ,pp. : 515-522

Oxford University Press

Access to resources Recommend Favorite

A Surview of Recent Patents on Anti-Infective Therapy for Clostridium difficile

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 8, Iss. 2, 2013-01 ,pp. : 139-149

Bentham Science Publishers

Access to resources Recommend Favorite

Long-Term Follow-Up of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridium difficile Infection in a Dual Solid Organ Transplant Recipient

By  

Case Reports in Gastroenterology, Vol. 9, Iss. 2, 2015-05 ,pp. : 156-159

Karger

Access to resources Recommend Favorite

Successful treatment of ulcerative colitis complicated by Sweet's syndrome by corticosteroid therapy and leukocytapheresis

By Terai Tomohiro  

Clinical Journal of Gastroenterology, Vol. 4, Iss. 3, 2011-06 ,pp. : 151-156

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of the Intestinal Microbiome of a Recovered Clostridium difficile Patient after Fecal Transplantation

By  

Digestion, Vol. 88, Iss. 4, 2013-12 ,pp. : 243-251

Karger

Access to resources Recommend Favorite